Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions

Executive Summary

• Else Nutrition announced a five‑year renewal of Israel’s largest Health Fund tender for its sterile and non‑sterile baby bottles and disposable nipples.
• The contract represents roughly 7 % of the company’s 2024 revenue, eliminating a potential revenue risk in the Israeli market.
• The renewal reinforces Else’s position as a leading supplier of hospital‑grade infant feeding accessories in Israel.

Key Details

• Contract Scope: Nationwide supply of sterile and non‑sterile baby bottles and disposable nipples to hospitals and maternity wards across Israel for five years.
• Revenue Impact: Approximate contribution of 7 % of Else Nutrition’s 2024 revenue; eliminates prior revenue risk from the Israeli business unit.
• Strategic Significance: Strengthens Else’s leadership in hospital‑grade infant feeding solutions and supports continued growth in institutional channels.
• Manufacturing & Logistics: Products manufactured by third‑party partners in Europe and Asia; distribution handled by independent logistics providers.
• Quote: “This renewal underscores the trust placed in Else's quality, reliability, and standards of care,” said Hamutal Yitzhak, Co‑Founder and CEO.

Notable Quotes

• “We are proud to continue serving Israeli hospitals and families at the earliest and most critical moments of life.” – Hamutal Yitzhak, Co‑Founder and CEO, Else Nutrition.